Get started
Author

Muhammad Umar Wahab

Observed names: Dr Muhammad Umar Wahab, M.U. Wahab
ORCID: 0000-0002-1424-0983
Observed ORCID: 0000-0002-1424-0983
OpenAlex ID: A5029623937
Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country
2022 · Muhammad Daoud Butt, Siew Chin Ong, et al. · International Journal of Environmental Research and Public Health · 79
PDF
An observational multi-center study on type 2 diabetes treatment prescribing pattern and patient adherence to treatment
2023 · Muhammad Daoud Butt, Siew Chin Ong, et al. · Scientific Reports · 27
PDF
Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study
2022 · Ibrar Ahmed, Umar Yousaf Raja, et al. · BMC Endocrine Disorders · 17
PDF
The Outcomes of Dapagliflozin Use in Real-Life Clinical Settings in Endocrinology Clinics of Islamabad, Pakistan
2020 · Matiullah Kamin, Osama Ishtiaq, et al. · Cureus · 7
PDF
Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients
2020 · Rafia Zameer, Matiullah Kamin, et al. · Cureus · 5
PDF
Real‐World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan
2026 · Arshad Hussain, Muhammad Umar Wahab, et al. · Diabetes Obesity and Metabolism · 2
Multicenter, Retrospective, observational study to evaluate the real-world use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in the Pakistani population with Type-2 diabetes (T2D)
2025 · Umar Yousaf Raja, Muhammad Umar Wahab, et al. · Pakistan Journal of Medical Sciences · 1
Current Trends and Availability of Injectable Therapy in Pakistan for Management of Diabetes Mellitus
2023 · Muhammad Shahzad Nawaz, Hafiza Shizza Rafique, et al. · International Journal of Pharmacy & Integrated Health Sciences · 1
PDF
Efficacy and Safety of Dulaglutide in Type 2 Diabetes Patients in Endocrinology Clinics of Islamabad, Pakistan
2021 · Matiullah Kamin, Sajjad Ali Khan, et al. · Indian Journal of Endocrinology and Metabolism · 1
Real-world safety and effectiveness of empagliflozin (Diampa®) alone or in combination with metformin (Diampa-M®) in patients with type 2 diabetes mellitus in Pakistan: a multicenter observational study
2026 · Muhammad Umar Wahab, Amanullah Bhalli, et al. · BMC Endocrine Disorders
Author response for "Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicenter Study from Pakistan"
2026 · Arshad Hussain, Muhammad Umar Wahab, et al. · Publons reviews and discussion
Author response for "Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicenter Study from Pakistan"
2026 · Arshad Hussain, Muhammad Umar Wahab, et al. · Publons reviews and discussion
Evaluation of Routine Biomarkers for Identifying Mody in Young-Onset Diabetes: A Retrospective Study from Pakistan Cohort
2025 · Yaseen Hussain, Menahil Rauf, et al. · SSRN Electronic Journal
IDF21-0395 Analyze the prevalence of DPN using VPT: Age, Duration of disease, BMI, HbA1c in T2DM patients – Cross Sectional study
2022 · M.U. Wahab, A. Umar · Diabetes Research and Clinical Practice
PDF
IDF21-0387 Efficacy of Dapagliflozin and Its Role on Microalbuminuria: Multicentric Real World Evidence from Pakistan
2022 · M.U. Wahab, S. Kalra, et al. · Diabetes Research and Clinical Practice
PDF
AACE2021-A-1035: Efficacy and Safety of Dulaglutide in Type 2 Diabetes Patients in Endocrinology Clinics of Islamabad, Pakistan
2021 · Matiullah Kamin, Sajjad Ali Khan, et al. · Endocrine Practice
Essential diagnostics and devices in primary care diabetes.
2021 · Muhammad Umar Wahab, Umar Yousaf Raja, et al. · PubMed
Efficacy and cardiovascular effects of dipeptidyl peptidase-4 (DPP4) inhibitors: a systematic review
2017 · Dr Muhammad Umar Wahab
Works count: 18
Citation count: 140
H-index: 5
I10-index: 3
Year
Topic
Type